American Academy of Allergy, Asthma and Immunology

58 articles about American Academy of Allergy, Asthma and Immunology

• Smoke Exposure Late in Pregnancy Might Boost Baby's Eczema Risk, American Academy of Allergy, Asthma and Immunology (AAAAI) Reveals

  3/5/2012

• Baxter International, Inc. Presents Long-Term Data on HyQ During American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting

  3/5/2012

• ISTA Pharmaceuticals, Inc. Highlights BEPREVE(R) Clinical Data at the 2011 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting

  3/23/2011

• Santarus Inc. and Pharming Group Announce RHUCIN Poster at American Academy of Allergy, Asthma and Immunology (AAAAI) 2011 Annual Meeting

  3/21/2011

• Oral Treatment Best for Milk Allergy, Finds American Academy of Allergy, Asthma and Immunology (AAAAI) Study

  3/21/2011

• Dyax Corp.'s KALBITOR(R) (ecallantide) Data Presented at American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting

  3/2/2010

• Data from Two Phase III Studies of Merck & Co., Inc.'s Investigational Asthma Drug Presented at American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting

  3/2/2010

• Data Presented at American Academy of Allergy, Asthma and Immunology (AAAAI) Reinforce Baxter International, Inc.'s Commitment to Making GAMMAGARD LIQUID Therapy More Convenient

  3/16/2009

• CyDex Pharmaceuticals Presents Phase 2 Clinical Trial Results for Captisol-Enabled(R) Budesonide/Azelastine Combination Solution Nasal Spray at American Academy of Allergy, Asthma and Immunology (AAAAI) Meeting

  3/16/2009

• Children Can Develop Tolerance to Egg Allergy, Study Published in American Academy of Allergy, Asthma and Immunology (AAAAI) Journal

  7/24/2008

• Sepracor, Inc. Presents Safety Data on OMNARIS(TM) AQ and OMNARIS(TM) HFA Nasal Sprays at American Academy of Allergy, Asthma and Immunology (AAAAI)

  3/17/2008

• Sepracor, Inc. Presents OMNARIS(TM) HFA Nasal Aerosol Large-Scale Phase II Study Data at American Academy of Allergy, Asthma and Immunology (AAAAI)

  3/17/2008

• Inspire Pharmaceuticals, Inc. Announces Poster Presentations at 2008 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting

  3/14/2008

• Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)

  3/7/2007

• Regeneron Pharmaceuticals, Inc. Release: IL-1 Trap Phase 3 Trial Data Presented at Annual Meeting of American Academy of Allergy, Asthma and Immunology (AAAAI)

  2/28/2007

• Inspire Pharmaceuticals, Inc. To Present Data At 2007 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting

  2/23/2007

• American Academy of Allergy, Asthma and Immunology (AAAAI) Release: Positive Final Results From EDEMA2 Trial With DX-88 For The Treatment Of Hereditary Angioedema Presented At American College of Allergy, Asthma and Immunology (ACAAI) Meeting

  11/14/2006

• American Academy of Allergy, Asthma and Immunology (AAAAI): Itchy Mouth May Be Tied To Produce, Ragweed

  8/2/2006

• American Academy of Allergy, Asthma and Immunology (AAAAI) Release: Accidental Peanut Ingestion Rate On The Decline, From JACI

  6/15/2006

• American Academy of Allergy, Asthma and Immunology (AAAAI) Release: Many Children With Moderate-To-Severe Reactions To Insect Stings Aren't Getting Treatment At A Hospital, From JACI

  5/15/2006